BioSpace News Archive

SkylineDx is excited to announce the scientific collaboration with the Multiple Myeloma (blood cancer) specialized department of the Wuerzburg University Medical Center II under the leadership of Prof. Dr. med. Martin Kortüm and Dr. med. Leo Rasche.

CARB-X is awarding Pattern Bioscience (formerly operating as Klaris Diagnostics), based in Austin, Texas, US, up to US$6.8 million in non-dilutive funding to develop a rapid identification and antimicrobial susceptibility test (ID/AST) to diagnose drug resistant infections quickly, and provide health professionals with vital information about which pathogen is causing the infection and which antibiotic is most likely to cure the infection.

iOnctura SA, a clinical stage biopharmaceutical company, developing a pipeline of next generation molecules targeting cancer and fibrosis, announces the addition of new members to its Clinical Advisory Board (CAB) with the appointment of Dr. Hendrik-Tobias Arkenau, Executive Medical Director, Sarah Cannon Research Institute, UK, and Dr. Jordi Rodón Ahnert, Clinical co-director MD Anderson Cancer Center.

Horizon Discovery Group plc (LSE: HZD) (“Horizon” “the Group” or “the Company”), a global leader in the application of gene editing and gene modulation technologies, today provides an unaudited pre-close trading update for the year ended 31 December 2019.

The Alpha Genesis Primate Research Center is utilizing its considerable resources to develop a much-needed vaccine to battle what looks to be an emerging pandemic.